ASRM 2024 Abstract Submission is Open!

Close Close Icon

Child-rearing ability and the provision of fertility services: an Ethics Committee opinion (2017)


  • Fertility programs may withhold services from prospective patients on the basis of well-grounded reasons that those patients will be unable to provide minimally adequate or safe care for offspring.
  • Fertility programs may provide services to prospective patients who would benefit from medical treatment except when significant harm to a future child is likely.
  • Fertility programs should develop written procedures for making a determination to withhold services when there are concerns about the childrearing capacities of prospective patients.
  • A program's assessment of a patient's inability to care for a child or potential to cause harm to a child should be made jointly among members of the program and, if indicated, consultation with appropriate other professionals (for example, with a mental-health professional), and should be documented.
  • Persons with disabilities should not be denied fertility services on the basis of disability.

Providers of infertility services are sometimes faced with patients who do not appear to be well situated to provide safe or adequate care for children. Treating these patients may lead to the birth of a child who is reared by parents who are psychologically unstable, abuse drugs, may abuse the child or the other parent, or present other risks to the well-being of the child. Accurate predictions about parental child-rearing ability are not easily made, and personnel in fertility programs may not feel equipped to make them. This poses an ethical dilemma in which clinicians must weigh the potential interests of future offspring against the needs and desires of infertile patients. The aim of this opinion is to provide guidance to fertility programs in such circumstances to facilitate each program's individualized decision-making. It addresses whether cliniciansmust provide services to persons whom they suspect might not be able to provide adequately for the child's welfare, or whether clinicians have an ethical obligation not to provide these services. This opinion also discusses the extent to which a clinician's own ethical views of minimally acceptable child-rearing and possible responsibility for the future child may be taken into account in appropriately deciding whether to accept a patient for infertility treatment.


Fertility specialists provide services that treat or bypass medical and nonmedical problems that interfere with the ability to have children. Fertility specialists ordinarily focus on medical aspects of the situation. Except in third-party reproduction, psychological screening or consultation with patients generally does not occur. Attention focused on the home or rearing situation of children born as a result of treatment is not common.

As with persons who reproduce without assistance, no systematic screening of patients seeking fertility services to investigate their ability or competency in rearing children has traditionally occurred or been thought to be appropriate, as would ordinarily occur in adoption. The desire to reproduce prompts a wide variety of individuals to seek infertility treatment, including subcategories of patients for whom questions of childrearing ability might legitimately arise. For example, while infrequent, many programs have had treatment requests from persons who have a history or current evidence of uncontrolled or untreated psychiatric illness, substance abuse, violent or criminal behavior, child abuse, previous loss of parental rights, or ongoing partner abuse. These factors and others may lead a fertility program to question whether such patients are likely to cause significant harm to a future child.

Concerns about child-rearing abilities of patients present a dilemma for fertility programs. As providers of medical services, programs do not routinely evaluate the child-rearing ability of their patients or conduct home studies as adoption agencies do, nor has it been thought their role to do so. There is no existing child to be placed for adoption and thus no need for the home studies and the scrutiny that occur in adoption. Medical factors have been the key determinant of whether treatment will be provided; some physicians argue that this should be the only consideration in deciding whether to provide services (1).

Fertility programs, however, are not totally removed from social and psychological considerations in providing treatment. Programs may obtain social or psychological history information from patients, either via intake forms or through conversations that occur during the course of treatment. Programs may require patients to meet with a counselor. Such counseling has become routine for patients using donor gametes and embryos or gestational carriers. Even though fertility programs do not seek to assess parenting adequacy specifically, pretreatment medical evaluation of patients might reveal potential problems, such as uncontrolled psychiatric illness, a history of child or spousal abuse, or substance abuse. In such situations, some programs and providers may be reluctant to proceed with treatments, either out of concern about their role in helping patients become parents who may be potentially harmful to their child or because of fears of legal liability. At the same time, practitioners may feel that they are not competent to make such predictions and should not be required to do so. Providers also may feel that it is necessary to respect the right of persons to have children if they so choose and to avoid charges of unlawful or improper discrimination in withholding services from them.

The problem is complicated because many interests are involved. The interest of future children having a safe home environment and minimally competent rearing parents must be reconciled with the interest of infertile persons receiving the treatment services they need to reproduce versus the provider's own sense of moral responsibility in deciding which patients to treat.


We analyze below the interests of offspring, infertile persons, and providers of fertility services.

It is difficult to reach optimal solutions for all situations, but the Committee believes that fertility programs should be attentive to the potential for serious child-rearing deficiencies in their patients. If they have a substantial, non-arbitrary basis for thinking that parents will provide inadequate or unsafe child-rearing, they should be free to refuse to provide treatment services to such patients. Because of the difficulty of making judgments reliably, however, clinicians should deny services only after investigation shows that there is a substantial basis for such judgments. In reaching such conclusions, it is imperative that programs not engage in prohibited or unjust discrimination. Given the great importance of procreation, infertile persons should not be denied services without a thorough review and determination jointly made by members of a multidisciplinary treatment team. However, fertility providers are not morally obligated to refuse services in all cases in which there might be a question about risk to the child. It is very difficult to make such complex judgments about potential future risk to offspring. Some will prefer to proceed with treatment, giving greater weight to the parents' desire to reproduce. Also, programs may adopt a written policy that they will provide fertility services to all persons who qualify medically except when significant harm to future children is likely.

The Welfare of Offspring

Entwined with the child-rearing ability of fertility patients are questions about the welfare of future offspring and the duty of prospective parents and those aiding them to avoid situations that may jeopardize child welfare. Helping parents achieve the birth of a child could be considered a morally worthwhile endeavor. The provision of reproductive treatments, unlike childbirth in unassisted reproduction, permits contemplation by third parties of the possibility of risks or harm to offspring born to a particular set of parents.

Many persons have argued that the well-being of offspring should be the primary consideration in determining whether medical services should be provided to treat infertility. Indeed, the Human Fertilisation and Embryology Act, setting up a regulatory authority for assisted reproductive technology in the United Kingdom, made this consideration explicit. It stated that treatment services should not be provided unless account has been taken of the welfare of any child who may be born as a result of treatment (2).

The well-being of offspring is an overriding ethical concern that should be considered in determining whether to provide infertility services. Respecting the interests of children in the context of infertility, however, poses an ethical paradox. In most instances, decisions about whether to provide a treatment will determine whether a child will be born at all, not whether the child will be born into a safe environment. In such cases, the only way to protect the child from the risks of concern would be to avoid its birth altogether.

A large body of philosophical and bioethical literature discusses the issue of harm to offspring from the very conditions of their conception or birth (3–11). Some commentators have concluded that unavoidable ‘‘harm’’ to a child from assisted reproduction can never be a valid reason to withhold services (3, 11). However, such a judgment takes too narrow a view of the relevance of offspring welfare in determining ethical conduct. Although a child may not, strictly speaking, be ‘‘harmed’’ as a result of fertility procedures that made its birth possible, concerns about future harm to offspring may be validly taken into account when making ethical assessments about those treatments. For some persons, the potential harm to the child alone is sufficient to justify this conclusion. Others might point to the significant costs and burdens that parental unfitness potentially imposes on the larger society.

Denying fertility services to those who might harm a child is not an easy judgment, and providers or policymakers should be very cautious in making such decisions. A wide range of parenting approaches or home environments are compatible with a child thriving and having a meaningful life, and persons having a rich and responsible parenting experience. The parents' prospective child-rearing would have to raise concerns regarding child protection and represent a very large deviation from a ‘‘good enough’’ home for concerns about the welfare of offspring to be relevant to ethical assessment or policy choice. Such assessment should be thorough and defensible after careful consideration of relevant factors.

The Interests of Infertile Persons

Another important consideration in assessing this issue is the interest of infertile patients in receiving services that will enable them to reproduce. Fertile persons have constitutional rights to have and rear children that the state cannot restrict except in extreme cases of harm. Indeed, persons with severe mental illness or developmental disability are protected against compulsory sterilization or contraception even when reproductive decisions may be rightly regarded as irresponsible or wrong. Infertile persons have the same rights and interests in reproducing as do fertile persons, and they should not be denied parenthood merely because they are infertile. Reproductive rights protected under the United States and state constitutions are rights against state interference, not rights to have physicians or the state provide requested services. In addition, constitutional rights protect individuals against interference or discrimination by government or governmental entities, but such protections usually do not extend to the behavior of persons in medical practice in the private sector. Federal and state anti-discrimination laws, however, do ban certain kinds of private sector discrimination in decisions to treat patients that largely focus on demographic features such as race, national origin, ethnicity, religion, sex, disability, sexual orientation, and gender identity (12). As long as the private-sector physician does not impermissibly discriminate under these laws, he or she may choose not to accept a fertility patient without violating that person's constitutional rights. While there is great dispute about what will count as a sufficient justification for governmental restrictions on reproduction, physicians might legitimately, when a clear case of a substantial risk of harm to offspring is shown, choose not to provide services that make such a birth or rearing situation possible.

As noted, such judgments may be difficult to make or support except in the clearest cases. Because of the importance of reproduction, judgments to deny treatment should be made only when there is a strong and substantial basis for doing so. In making them, providers should pay special attention to treating equally persons with disabilities who request fertility services. Persons with disabilities are able to rear children, and should not be disqualified from doing so merely because of their disability (13). The federal Americans with Disabilities Act, which applies equally to governmental and private-sector fertility clinics, prohibits denying persons with disabilities access to infertility services if the denial is based on ill-founded doubts or stereotypes about their ability to rear and parent (14).

Provider Autonomy

An important difference between reproduction by fertile and infertile persons is that fertile individuals do not need the help of physicians to become pregnant. Persons who seek the assistance of a physician to reproduce necessarily involve the physician in the outcome that they seek. Requests for reproductive assistance thus also raise the question of whether physicians are obligated to treat all patients who seek their services. Although there is a strong presumption in favor of an obligation to treat all persons in need, physician and professional autonomy is also an important value. Ordinarily, both parties are free to decide whether to enter into a doctor-patient relationship and, once in it, whether, with adequate notice to the patient, to terminate that relationship. Unless the conditions of their employment require otherwise, physicians providing fertility services are generally free not to provide services to individuals as they choose, subject only to federal and state laws that prohibit discrimination on statutorily enumerated grounds.

Regarding the limits of provider autonomy when decisions about whether to treat are based solely on patient sexual orientation, gender identity, or marital status, treatment denials are inappropriate in part because the data that show child-rearing and offspring welfare outcomes are similar to those achieved in traditional family structures (15, 16). Even when patients seem at elevated risk of being unable to provide safe or adequate care for children, individualized assessments are required to avoid applying unjustified inferences from group characteristics to individuals.

Physicians faced with individuals or couples who create significant concerns about the safety of a potential child may have very good reasons for choosing not to treat them. Precisely because fertility services could result in a child, physicians may reasonably believe that they have a moral responsibility for the situation of the resulting child and choose not to help bring about such an outcome. If they take that view and do not deny treatment solely on the basis of disability or other impermissible factor, they may take the welfare of resulting children into account in deciding whether to provide services.

By the same token, some providers may believe that they have an obligation to treat all patients who would benefit from medical treatment and should not be required to assess a patient's child-rearing abilities or other child-welfare concerns. This too is a reasonable position, except when significant harm to a future child is likely. Physicians and providers with this treatment philosophy should be free to accept persons for treatment as long as they have a reasonable basis for thinking that the child will not suffer significant harm from being raised by these parents. Professional autonomy thus has two aspects. It entitles physicians to choose not to treat persons whom they think will be inadequate child-rearers (as long as they comply with antidiscrimination laws). It also generally entitles them to treat such patients if they choose.


Offspring welfare is a valid consideration that fertility programs may take into account in accepting patients and providing services as long as they do not discriminate on the basis of disability or other impermissible factors. However, it does not follow that physicians are morally obligated to withhold such services, except when significant harm to future children is likely. Physician autonomy entitles physicians to provide medical services if they choose, but they are not usually obligated to do so. While practitioners and clinics may—except in the case of impermissible discrimination—make their own moral decisions about whether to accept individuals as patients, their decisions should be based on empirical evidence, not stereotype or prejudice. For example, they should not assume that a history of social or psychological problems or presence of a serious disability automatically disqualifies someone from being a capable rearing parent.

A decision to deny treatment to patients who raise child-protection concerns calls for careful inquiry and should be dependent on evidence. To aid in the process, fertility programs should develop explicit policies or procedures for handling such situations. Written policies might address such matters as the information and evaluation that will be required of potential patients and what conditions would preclude medical treatment for infertility (for example, uncontrolled or untreated psychiatric illness, substance abuse, a history of or ongoing physical or emotional abuse, or a history of perpetrating physical or emotional abuse). Programs also should establish a procedure for making and documenting such assessments when questions about the child-rearing adequacy of potential parents arise. This might involve evaluation by a mental-health professional and consultation with other experts culminating in a group assessment or review prior to a final determination.


This report was developed by the Ethics Committee of the American Society for Reproductive Medicine as a service to its members and other practicing clinicians. While this document reflects the views of members of that Committee, it is not intended to be the only approved standard of practice or to dictate an exclusive course of treatment in all cases. This report was approved by the Ethics Committee of the American Society for Reproductive Medicine and the Board of Directors of the American Society for Reproductive Medicine.

The following members of the ASRM Ethics Committee participated in the development of this document. All Committee members disclosed commercial and financial relationships with manufacturers or distributors of goods or services used to treat patients. Members of the Committee who were found to have conflicts of interest based on the relationships disclosed did not participate in the discussion or development of this document.

Judith Daar, J.D.; Jean Benward, M.S.W.; Lee Collins, J.D.; Joseph Davis, D.O.; Owen Davis, M.D.; Leslie Francis, Ph.D., J.D.; Elena Gates, M.D.; Elizabeth Ginsburg, M.D.; Susan Gitlin, Ph.D.; Sigal Klipstein, M.D.; Laurence McCullough, Ph.D.; Richard Reindollar, M.D.; Ginny Ryan, M.D.; Mark Sauer, M.D., M.S; Rebecca Sokol, M.D., M.PH; Sean Tipton, M.A.; Lynn Westphal, M.D.


  1. 1. Gurmankin AD, Caplan AL, Braverman AM. Screening practices and beliefs of assisted reproductive technology programs. Fertil Steril 2005:61–7.
  2. Human Fertilisation and Embryology Act of 1990. In: . In: Morgan D, Lee RG, editors. Blackstone's guide to the Human Fertilisation& Embryology Act 1990. London: Blackstone Press Limited; 1991:194.
  3. Heyd D. Genethics: moral issues in the creation of people. Berkeley: University of California Press; 1992.
  4. Coleman CH. Conceiving harm: disability discrimination in assisted reproductive technologies. UCLA L Rev 2002;50:17.
  5. Peters PG Jr. Protecting the unconceived: nonexistence, avoidability, and reproductive technology. Ariz L Rev 1989;31:487–558.
  6. Brock D. The non-identity problem and genetic harms—the case of wrongful handicaps. Bioethics 1995;9:269.
  7. Parflt D. On doing the best for our children. In: . In: BaylesMD, editor. Ethics and population. Cambridge: Schenkman; 1976.
  8. Green RM. Parental autonomy and the obligation not to harm one's child genetically. J Law Med Ethics 1997;25:10.
  9. Steinbock B, McClamrock R. When is birth unfair to the child? Hastings Cent Rep 1994;24:15.
  10. Cohen CB. The morality of knowingly conceiving children with serious conditions: an expanded ‘‘wrongful life’’ standard. In: . In: Fotion N, Heller JC, editors. Contingent future persons. Boston: Kluwer Academic Publishers;1997:33.
  11. Roberts M. Child versus childmaker: future persons and present duties in ethics and the law. Lanham: Rowman & Littlefleld; 1998.
  12. Robertson JA. Procreative liberty, harms to offspring, and assisted reproduction. Am J Law Med 2004;30:7–40.
  13. National Council on Disabilities. Rocking the cradle: Ensuring the rights of parents with disabilities and their children, Available at:; 2012.
  14. Americans with Disabilities Act, 42 U.S.C. x 12102 (1990), amended by the Americans with Disabilities Amendments Act, Pub. L. No. 110–325(2008).
  15. Ethics Committee of the American Society for Reproductive Medicine. Access to fertility treatment by gays, lesbians, and unmarried persons. Fertil Steril 2013;100:1524–7.
  16. Ethics Committee of the American Society for Reproductive Medicine. Access to fertility services by transgender persons. Fertil Steril 2015;104:1111–5.

Topic Resources

View more on the topic of infertility
Document Icon

Tobacco or marijuana use and infertility: a committee opinion (2023)

In the United States, approximately 21% of adults report some form of tobacco use, although 18% report marijuana use. View Committee Opinion
Advocacy Icon

National Infertility Awareness Week

April 21-27, 2024, is National Infertility Awareness Week (NIAW)! This year’s theme is “Leave Your Mark.”

View the NIAW Toolkit
Videos Icon

Journal Club Global: The future of REI Fellowship training: debating opportunities and threats

This exciting collaboration discusses the controversy and future directions for the field of Reproductive Endocrinology and Infertility medicine. View the Video
Videos Icon

Journal Club Global: Infertility and Subclinical Hypothyroidism

The impact of treating SCH on fertility, obstetric outcomes, and offspring neurocognitive development is debated in the literature. View the Video
Announcement Icon

ASRM reacts to Alabama legislation

We are pleased that the legislation passed into law by the Alabama General Assembly will at least allow our members in the state to care for their patients.

View the Press Release
Announcement Icon

IVF at the SOTU: Fertility care expected to be major focus at State of the Union

Protecting access to IVF care is expected to be a major theme of the State of the Union on Thursday.

View the Press Release
Document Icon

Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion (2024)

Clinicians should encourage disclosure between intimate partners but should maintain confidentiality where there is no harm to the partner and/or offspring. View the Committee Opinion
Document Icon

Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)

Telemedicine has the potential to increase access to and decrease the cost of care. View the Committee Opinion
Announcement Icon

ASRM Responds to Proposed Alabama Legislation

We are proud of our Alabama members and their patients, who have been such incredible advocates working to motivate their legislators to protect IVF.

View the Press Release
Announcement Icon

Senate Budget Hearing is Well Timed Following Alabama IVF Ruling

ASRM statement regarding the Senate Budget Committee’s hearing entitled: No Rights to Speak of: The Economic Harms of Restricting Reproductive Freedom.

View the Press Release
Announcement Icon

ASRM Responds to Senate’s Failure to Pass Access to Family Building Act

We are disappointed by the Senate’s failure to meet the moment and pass federal legislation protecting access to in vitro fertilization (IVF).

View the Press Release
News Icon

What's New from the Fertility and Sterility Family of Journals

Here’s a peek at this month’s issues from our family of journals! As an ASRM Member, you can access all of our journals.
Read More about the newest articles
Announcement Icon

ASRM Condemns Profoundly Misguided and Dangerous Court Decision in Alabama

In LePage v Mobile Infirmary Clinic, the Alabama Supreme Court made a decision that flies in the face of medical reality and the needs of the citizens.

View the Press Release
News Icon

NEW from ASRM Academy: Basic Infertility for Healthcare Providers

ASRM is proud to introduce our updated course: Basic Infertility for Healthcare Providers.  Learn more with an overview from Instructional Designer, Harriet Smith, MEd
News Icon

What's New from the Fertility and Sterility Family of Journals

Here’s a peek at this month’s issues from our family of journals! As an ASRM Member, you can access all of our journals. Not yet a member? Click here(no link) to learn more. Find More
Announcement Icon

ASRM applauds introduction of Access to Family Building Act of 2024

ASRM is thrilled by the introduction of the Access to Family Building Act 

View the Press Release
News Icon

Resource Roundup: Thyroid Health

January is Thyroid Health Awareness Month! View the resource roundup!
Document Icon

Definition of infertility: a committee opinion (2023)

‘‘Infertility’’ is a disease, condition, or status characterized by several factors. View the Committee Opinion
Podcast Icon

ASRM Today: ASRM Advocacy Training Initiative with Becca O'Connor

In this episode, ASRM Today talks with Becca O'Connor, of the ASRM Center for Policy and Leadership, about their first-of-its-kind advocacy training initiative. Listen to the Episode
Podcast Icon

ASRM Today: The Business of Infertility Treatment with Hary Hokianto

In this episode from ASRM 2023 in New Orleans, I'm talking with Hary Hokianto about the business of infertility treatment. Listen to the Episode
Document Icon

Diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion (2023)

It is the responsibility of the clinician to assess for erectile dysfunction, ejaculatory dysfunction, or diminished libido in men presenting for infertility. View the Committee Opinion
Announcement Icon

Doctors Group Launches Ad Campaign for Ohio Issue 1

ASRM announced the launch of an ad campaign throughout Ohio urging voters to select “Yes on Issue 1” when they head to the polls on November 7.

View the Press Release
Videos Icon

Journal Club Global - Actualización en la suplementación con progesterona en fase lútea para transferencias de embriones congelados

Efectividad del rescate de progesterona en mujeres que presentan niveles bajos de progesterona circulante alrededor del día de la transferencia de embriones View the Video
Document Icon

Endometriosis and infertility: a committee opinion (2012)

Women with endometriosis typically present with pelvic pain, infertility, or an adnexal mass, and may require surgery. View the Committee Opinion
Document Icon

The International Glossary on Infertility and Fertility Care, 2017†‡§ (2017)

Terms and definitions currently used infertility care, infertility and medically assisted reproduction (MAR) can have different meanings that are dependent upon the setting, their usage in research or clinical interventions, or among diverse populations.
View the Committee Joint Guideline
Coding Icon

Post Vasectomy Infertility

If a husband has had a vasectomy, does the sterilization code apply to the wife's visits? View the Answer
Coding Icon

Pregnancy Of Uncertain Viability Ultrasound

My staff is telling me that I am getting reimbursed for the first sonogram and OB visit (using ICD 10 code for pregnancy of uncertain viability – O36.80X0. View the Answer
Coding Icon

Pregnancy Ultrasound

Our practice does routine ultrasounds (sac check- 76817) at the end of an IVF cycle and bill with a diagnosis code O09.081, pregnancy resulting from ART.  View the Answer
Coding Icon

Self-referred New Patient

A patient self-refers to our physician for an initial new patient consultation instead of referred by another physician, how do we code for the consult? View the Answer
Coding Icon

Telephone Consult

Does a physician need to speak directly to a patient to code for a telephone consult (99371-99373) or can a staff member relay physician notes to patients? View the Answer
Coding Icon

Testing With No History of Infertility

What diagnosis codes should  providers submit to insurance carriers while trying to evaluate fertility issues? View the Answer
Coding Icon

Psychological Evaluation

Many REs require patients (and their spouses/partners) who are considering using donor gametes to see an infertility counselor first. View the Answer
Coding Icon

Surgery Coding

I took the ASRM coding course, and in that course, coding for bilateral neosalpingostomies was coded using only a dx of N70.11 (hydrosalpinx). View the Answer
Coding Icon


Should other ovarian dysfunction (diagnosis code E28.8) or unspecified ovarian dysfunction (diagnosis code E28.9) can be used for an IUI or an IVF cycle View the Answer
Coding Icon

Infertility Consult

Does ASRM have any examples of evaluation and management documentation for patients being seen for an initial infertility evaluation? View the Answer
Coding Icon

Infertility Consult by Nurse

What code is used for a nurse practitioner seeing a fertility patient for the first time? View the Answer
Coding Icon

Initial Visit for Infertility With No Mandated Coverage

What code would be appropriate for an initial visit for infertility?  View the Answer
Coding Icon

Monitoring E&M

Our group would like to know if others are billing an evaluation and management code for ultrasound and blood draw visits? View the Answer
Coding Icon

New vs Established Patient

How soon can you bill as a new infertility patient? View the Answer
Coding Icon

General E&M Consult

Recently we have received a “re-code” on a new patient (we billed a 99203 and the insurance re-coded it to a 99213).  View the Answer
Coding Icon

Hysteroscopy Recurrent Implantation Failure

What is the appropriate ICD-10 code for recurrent implantation failure?  View the Answer
Coding Icon

Diagnosis of Infertility for IVF Procedure

How important is it to have accurate documentation of the type of infertility diagnosis for IVF procedures?  View the Answer
Coding Icon

Diagnostic Testing of an Infertile Couple

The Z31.41 is or is not the correct code to use for diagnostic testing of an infertile couple? And If so can if be used as the primary and only code? View the Answer
Coding Icon

D&C Under Ultrasound Guidance

What are the CPT codes and ICD-10 codes for coding a surgical case for a patient with history of Stage B adenocarcinoma of the cervix ... View the Answer
Coding Icon

Blood Draws

If a patient comes in only for a blood draw (venipuncture) and is seen only by the lab technician (not an MD, PA, or NP), may we bill for a (minimal) office visit? View the Answer
Coding Icon

Blood Tests

Patients are requesting to have lab work drawn from the female patient moved to the males account due to the female fertility coverage being maxed out.  View the Answer
Coding Icon

Male Infertility

A summary of common codes for Male Infertility compiled by the ASRM Coding Committee View the Coding Summary
Document Icon

ASRM müllerian anomalies classification 2021

The Task Force set goals for a new classification and chose to base it on the iconic AFS classification from 1988 because of its simplicity and recognizability. View the Committee Opinion
Document Icon

Intracytoplasmic sperm injection (ICSI) for non–male factor indications: a committee opinion (2020)

Intracytoplasmic sperm injection is frequently used in combination with assisted reproductive technologies. View the Committee Document
Document Icon

Moving innovation to practice: an Ethics Committee opinion (2021)

The introduction of new strategies, tests, and procedures into clinical practice raises challenging ethical issues. View the Committee Opinion
Document Icon

Fertility evaluation of infertile women: a committee opinion (2021)

Diagnostic evaluation for infertility in women should be conducted in a systematic, expeditious, and cost-effective manner. View the Committee Opinion
Document Icon

Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion (2019)

The Ethics Committee recommends that in vitro fertilization (IVF) centers develop patient-centered policies regarding requests for futile treatment.  View the Committee Opinion
Document Icon

Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion (2020)

Pretreatment evaluation, indications, treatment regimens, and complications of gonadotropin treatment. View the Committee Opinion
Document Icon

Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review (2019)

Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions. View the Joint Statement
Document Icon

Guidance for Providers Caring for Women and Men Of Reproductive Age with Possible Zika Virus Exposure (Updated 2019)

This ASRM guidance specifically addresses Zika virus infection issues and concerns of individuals undergoing assisted reproductive technologies (ART). View the Guideline
Document Icon

Current recommendations for vaccines for female infertility patients: a committee opinion (2018)

Encounters for infertility care are opportunities to assess and update immunization status. View the Committee Opinion
Document Icon

American Society for Reproductive Medicine position statement on uterus transplantation: a committee opinion (2018)

Following the birth of the first child from a transplanted uterus in Gothenburg, Sweden, in 2014, other centers worldwide have produced scientific reports. View the Committee Opinion
Document Icon

Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline (2017)

This review evaluates if uterine myomas impact likelihood of pregnancy and pregnancy loss, and if myomectomy influences pregnancy outcomes. View the Guideline
Document Icon

Subclinical hypothyroidism in the infertile female population: a guideline (2015)

There is controversy regarding whether to treat subtle abnormalities of thyroid dysfunction in the infertile female patient. View the Committee Guideline
Document Icon

Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement (2014)

Clinical trials testing infertility treatments often do not report on the major outcomes of interest to patients and clinicians and the public. View the Guideline

Topic Resources

View more on legal/ethical issues
Webinars Icon

Apr 30, 2024, 3:00PM CT - "What is an Embryo’? Historical, psychological, and legal answers and implications

While an embryo is defined as “a fertilized egg that has begun cell division”, the meaning ascribed to embryos is far more complex.

Register Now
Document Icon

Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion (2023)

Planned oocyte cryopreservation is an ethically permissible procedure that may help individuals avoid future infertility. View the Committee Opinion
Document Icon

Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)

Telemedicine has the potential to increase access to and decrease the cost of care. View the Committee Opinion
Podcast Icon

ASRM Today: Policy Matters: Policy Roundup

On this episode of Policy Matters the ASRM Government Affairs Office brings us up to date on the past year of policy news and advocacy. Listen to the Episode
Document Icon

Interests, obligations, and rights in gamete and embryo donation: an Ethics Committee opinion (2019)

This Ethics Committee report outlines the interests, obligations, and rights of all parties involved in gamete and embryo donation: both males and females who choose to provide gametes or embryos for use by others, recipients of donated gametes and embryos, individuals born as a result of gamete or embryo donation, and the programs that provide donated gametes and embryos to patients. View the Committee Opinion
Legal Icon

The Supreme Court Overturns Right to Abortion, Raising Questions and Uncertainties for ART Patients and Providers

A summary of the U.S. Supreme Court’s ruling and various opinions in Dobbs v. Jackson Mississippi Women’s Health. View the Column
Document Icon

Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion (2022)

Providers may conclude that the medical risks of fertility treatment for a given patient are too high, in which case it is ethical for them to decline to provide treatment. View the Committee Opinion
Document Icon

Access to fertility services by transgender and nonbinary persons: an Ethics Committee opinion (2021)

The provision of fertility services to transgender individuals and the denial of access to fertility services is not justified. View the Committee Opinion
Document Icon

Interpretation of clinical trial results: a committee opinion (2020)

Evidence from clinical trials is fundamental to ethical medical practice. View the Committee Opinion
Document Icon

Ethics in embryo research: a position statement by the ASRM Ethics in Embryo Research Task Force and the ASRM Ethics Committee (2020)

Scientific research using human embryos advances human health and offspring well-being and provides vital insights into the mechanisms for reproduction and disease. Research involving human embryos is ethically acceptable if it is likely to provide significant new knowledge that may benefit human health, well-being of the offspring, or reproduction. View the Committee Opinion
Document Icon

Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes (2020)

A patient request to transfer embryos into her body in a location or at a time when pregnancy is highly unlikely ... View the Committee Opinion
Document Icon

Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion (2018)

Preimplantation genetic testing for monogenic diseases for adult-onset conditions is ethically permissible for a range of conditions including when the condition is serious and no safe, effective interventions are available. View the Committee Document
Document Icon

Using family members as gamete donors or gestational carriers (2017)

The use of adult intrafamilial gamete donors and gestational surrogates is generally ethically acceptable when all participants are fully informed. View the Committee Document
Document Icon

Financial ‘‘risk-sharing’’ or refund programs in assisted reproduction: an Ethics Committee opinion (2016)

Financial ‘‘risk-sharing’’ fee structures in assisted reproduction programs charge patients a higher initial fee but provide reduced fees for subsequent cycles and often a partial or complete refund if treatment fails. View the Committee Document
Document Icon

Disclosure of medical errors involving gametes and embryos: an Ethics Committee opinion (2016)

Medical providers have an ethical duty to disclose clinically significant errors involving gametes and embryos as soon as they are discovered. Clinics also should have written policies in place for reducing and disclosing errors. View the Committee Document
Document Icon

Informed consent and the use of gametes and embryos for research: a committee opinion (2014)

The ethical conduct of human gamete and embryo research depends upon conscientious application of principles of informed consent. View the Committee Opinion

Ethics Opinions

Ethics Committee Reports are drafted by the members of the ASRM Ethics Committee on the tough ethical dilemmas of reproductive medicine.
Ethics Committee teaser

Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion (2023)

Planned oocyte cryopreservation is an ethically permissible procedure that may help individuals avoid future infertility.
Ethics Committee teaser

Ethical obligations in fertility treatment when intimate partners withhold information from each other: an Ethics Committee opinion (2024)

Clinicians should encourage disclosure between intimate partners but should maintain confidentiality where there is no harm to the partner and/or offspring.
Ethics Committee teaser

Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)

Telemedicine has the potential to increase access to and decrease the cost of care.
Ethics Committee teaser

Misconduct in third-party assisted reproductive technology by participants and nonmedical professionals or entities: an Ethics Committee opinion (2023)

In some instances, it is ethically permissible for the physician to either disclose material information to the affected party or to decline to provide or continue to provide care.

More Resources

MAC 2021 teaser
ASRM Academy on the Go

ASRM MAC Tool 2021

The ASRM Müllerian Anomaly Classification 2021 (MAC2021) includes cervical and vaginal anomalies and standardize terminology within an interactive tool format.

View the MAC Tool
EMR Phrases teaser
Practice Guidance

EMR Shared Phrases/Template Library

This resource includes phrases shared by ASRM physician members to provide a template for individuals to create their own EMR phrases.

View the library
Practice Committee Documents teaser

ASRM Practice Documents

These guidelines have been developed by the ASRM Practice Committee to assist physicians with clinical decisions regarding the care of their patients.

View ASRM Practice Documents
Ethics Committee teaser

ASRM Ethics Opinions

Ethics Committee Reports are drafted by the members of the ASRM Ethics Committee on the tough ethical dilemmas of reproductive medicine.

View ASRM Ethics Opinions
Coding Corner general teaser
Practice Guidance

Coding Corner Q & A

The Coding Corner Q & A is a list of previously submitted and answered questions from ASRM members about coding. Answers are available to ASRM Members only.

View the Q & A
Covid-19 teaser
Practice Guidance

COVID-19 Resources

A compendium of ASRM resources concerning the Novel Corona virus (SARS-COV-2) and COVID-19.

View the resources
Couple looking at laptop for online patient education materials

Patient Resources provides a wide range of information related to reproductive health and infertility through patient education fact sheets, infographics, videos, and other resources.

View Website